Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
On July 15th, Cannara Biotech Inc. (LOVE:TSX, LOVFF:OTC, BUY $3.00 Target) reported record Q3/26 revenue of $31.8M (+16% YoY) and adjusted EBITDA of $8.5M (+11% YoY), both ahead of our estimates and marking a rebound from the seasonally soft Q2. Gross revenue reached...
— Ben Pirie & Nicholas Cortellucci
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Cannara Biotech Inc.
More institutional theses from Atrium Research
Zentek is an advanced materials company developing the Albany graphite deposit in Ontario alongside commercializing graphene coatings. The investment thesis...
BP Silver Corp. is a mineral exploration company focused on district-scale silver discoveries in Bolivia's historic silver belts. The analyst's bullish...
iFabric expanded retail distribution for its performance scrubs line into Target and international club retailers, supporting substantial revenue growth.